Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-22-036835

Director sold 2,700 shares at $9.48 ($25,593)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mitchell Stephen Ray Director 2022-06-13 Sale −2,700 $9.48 $25,593 6,515 D
Open-market sales · 2,700 sh · avg $9.48 · $25,593
Loading xslF345X03/doc4.xml…